These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10900926)

  • 1. [The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].
    Chirkov VP; Popov AF
    Med Parazitol (Mosk); 2000; (2):56-8. PubMed ID: 10900926
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview: immunology of malaria and progress in malaria vaccine development.
    Tharavanij S
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
    [No Abstract]   [Full Text] [Related]  

  • 3. The hope but challenge for developing a vaccine that might control malaria.
    Good MF
    Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
    Sutherland CJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria vaccine development: lessons from the field.
    Todryk S; Bejon P
    Eur J Immunol; 2009 Aug; 39(8):2007-10. PubMed ID: 19672893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
    Patarroyo ME; Patarroyo MA
    Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
    Ballou WR; Kester KE; Heppner DG
    Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
    [No Abstract]   [Full Text] [Related]  

  • 8. [NANP]19-5.1. A malaria vaccine field trial in Nigerian children.
    Reber-Liske R; Salako LA; Matile H; Sowunmi A; Stürchler D
    Trop Geogr Med; 1995; 47(2):61-3. PubMed ID: 8592764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular strategy for parasitism and vaccine development of falciparum malaria].
    Horii T
    Tanpakushitsu Kakusan Koso; 2001 Dec; 46(15):2154-62. PubMed ID: 11762075
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.
    Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS
    Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasitology. Malaria--from infants to genomics to vaccines.
    Long CA; Hoffman SL
    Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of vaccines against falciparum malaria.
    Ramalingam S; Mathai E
    Natl Med J India; 1996; 9(3):120-4. PubMed ID: 8664822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinating with the genome: a Sisyphean task?
    Coppel RL
    Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunological challenge to developing a vaccine to the blood stages of malaria parasites.
    Good MF; Stanisic D; Xu H; Elliott S; Wykes M
    Immunol Rev; 2004 Oct; 201():254-67. PubMed ID: 15361246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria vaccines: the stage we are at.
    Todryk SM; Hill AV
    Nat Rev Microbiol; 2007 Jul; 5(7):487-9. PubMed ID: 17571459
    [No Abstract]   [Full Text] [Related]  

  • 16. [Soluble antigens of intra-erythrocyte stages of Plasmodium falciparum: diagnostic and vaccinal value].
    Cruz Cubas AB; Gentilini M; Danis M; Monjour L
    Pathol Biol (Paris); 1993 May; 41(5):495-9. PubMed ID: 8414684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of human vaccine research and development: malaria.
    Girard MP; Reed ZH; Friede M; Kieny MP
    Vaccine; 2007 Feb; 25(9):1567-80. PubMed ID: 17045367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
    Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS
    Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine.
    Chen Q
    Microbes Infect; 2007 May; 9(6):777-83. PubMed ID: 17398133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria vaccines: from laboratory to field.
    Epidemiol Bull; 1994 Mar; 15(1):1-8. PubMed ID: 8011432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.